Continuing Our Commitment To Being Different
When ProStrakan laid down roots in the US, we made a commitment to address the unmet needs of oncology patients and the healthcare professionals who care for them.
Today, those roots are stronger than ever as we continue to make a difference with SANCUSO® (Granisetron Transdermal System), a treatment for chemotherapy induced nausea and vomiting (CINV), and a product in development for breakthrough cancer pain.